Transgene Tasly (Tianjin) BioPharmaceutical Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Transgene Tasly (Tianjin) BioPharmaceutical General Information

Description

Manufacturer of immunotherapeutic products. The company develops and commercializes biotechnology products, including monoclonal antibody for development in inflammation and cancer, oncolytic viral immunotherapy to treat solid tumors, HBV therapeutic vaccine, HCV therapeutic vaccine and a second generation oncolytic virus developed in cancer for the Chinese market.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Tianjin
  • China
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Corporate Office
  • Tianjin
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transgene Tasly (Tianjin) BioPharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Transgene Tasly (Tianjin) BioPharmaceutical‘s full profile, request access.

Request a free trial

Transgene Tasly (Tianjin) BioPharmaceutical Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Transgene Tasly (Tianjin) BioPharmaceutical‘s full profile, request access.

Request a free trial

Transgene Tasly (Tianjin) BioPharmaceutical FAQs

  • When was Transgene Tasly (Tianjin) BioPharmaceutical founded?

    Transgene Tasly (Tianjin) BioPharmaceutical was founded in 2010.

  • Where is Transgene Tasly (Tianjin) BioPharmaceutical headquartered?

    Transgene Tasly (Tianjin) BioPharmaceutical is headquartered in Tianjin, China.

  • What industry is Transgene Tasly (Tianjin) BioPharmaceutical in?

    Transgene Tasly (Tianjin) BioPharmaceutical’s primary industry is Pharmaceuticals.

  • Is Transgene Tasly (Tianjin) BioPharmaceutical a private or public company?

    Transgene Tasly (Tianjin) BioPharmaceutical is a Private company.

  • What is the current valuation of Transgene Tasly (Tianjin) BioPharmaceutical?

    The current valuation of Transgene Tasly (Tianjin) BioPharmaceutical is .

  • What is Transgene Tasly (Tianjin) BioPharmaceutical’s current revenue?

    The current revenue for Transgene Tasly (Tianjin) BioPharmaceutical is .

  • Who are Transgene Tasly (Tianjin) BioPharmaceutical’s investors?

    Transgene has invested in Transgene Tasly (Tianjin) BioPharmaceutical.

  • When was Transgene Tasly (Tianjin) BioPharmaceutical acquired?

    Transgene Tasly (Tianjin) BioPharmaceutical was acquired on 20-Aug-2018.

  • Who acquired Transgene Tasly (Tianjin) BioPharmaceutical?

    Transgene Tasly (Tianjin) BioPharmaceutical was acquired by Tasly Holding Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process